137863-20-8,
(S)-benzyl 2-(N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoate,
Valsartan benzyl ester,
UNII-2P0MPU907C,
Valsartan related compound C,
2P0MPU907C,
[(S-N-VALERYL-N-([2'-(1H-TETRAZOLE-5-YL)BIPHEN-4-YL]METHYL)-VALINE BENZYL ESTER),
(S)-benzyl 2-(N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanoate,
Benzyl (2S)-3-methyl-2-(N-((4-(2-(1H-1,2,3,4-tetrazol-5-yl)phenyl)phenyl)methyl)pentanamido)butanoate,
Benzyl (2S)-3-methyl-2-(pentanoyl((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)amino)butanoate,
benzyl (2S)-3-methyl-2-[N-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoate,
L-Valine, N-(1-oxopentyl)-N-((2'-(2H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, phenylmethyl ester,
Valsartan impurity B [EP],
Benzyl (2S)-3-Methyl-2-[pentanoyl[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]amino]butanoate,
L-Valine, N-(1-oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, phenylmethyl ester,
Valsartan related compound C [USP],
Valsartan related compound C RS [USP],
EC 604-047-3,
SCHEMBL2691,
CTK8B5686,
DTXSID70160342,
VXKKFWDUSKMRNO-LJAQVGFWSA-N,
BCP13367,
ANW-49606,
MFCD12407184,
SC1410,
ZINC65749015,
AKOS015854417,
AKOS015899738,
ACN-026593,
AK-39368,
BR-39368,
AB0088233,
AX8164351,
TR-005023,
FT-0675773,
S-7513,
I14-11667,
benzyl N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-N-pentanoyl-L-valinate,
N-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]-N-valeryl-(L)-valine benzyl ester,
Valsartan Related Compound C, United States Pharmacopeia (USP) Reference Standard,
(N-VALERYL-N-{[2'-(1HTETRAZOLE-5-YL)BIPHENYL-4-YL]METHYL}-L-VALINEBENZYL ESTER)(Valsartan Related Compound C), Pharmaceutical Secondary Standard; Certified Reference Material,
(s)-benzyl 2-(n-((2-(1h-tetrazol-5-yl)-[1,1-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoate,
(S)-Benzyl 2-(N-((2;-(1H-tetrazol-5-yl)-[1,1;-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoate,
(S)-N-(1-benzyloxycarbonyl-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amine,
(S)-N-(1-benzyloxycarbonyl-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'-(1H-tetrazol-5-yl)bi-phenyl-4-ylmethyl]-amine,
(S)-N-(1-Benzyloxycarbonyl-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]-amine,
benzyl (2S)-3-methyl-2-[N-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoate,
Benzyl (2S)-3-Methyl-2-[pentanoyl-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]amino]butanoate,
benzyl (2S)-3-methyl-2-[pentanoyl-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoate,
N-[2 pound feminine-(1H-tetrazol-5-yl)biphenyl-4-yl methyl]-N-Valeryl-(L)-Valine benzyl ester,
Diovan,
Valsartan EP Impurity B,
CB11822,
CS-O-08395,
CID11283894,
Benzyl (2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoate,